Sonova (OTCMKTS:SONVY) Stock Rating Lowered by Barclays

Barclays downgraded shares of Sonova (OTCMKTS:SONVY) from a strong-buy rating to a hold rating in a research report released on Wednesday,Zacks.com reports.

SONVY has been the topic of a number of other reports. UBS Group raised Sonova to a “hold” rating in a report on Tuesday, August 13th. The Goldman Sachs Group upgraded Sonova to a “strong sell” rating in a research report on Tuesday, October 22nd.

Sonova Stock Up 1.6 %

SONVY opened at $69.75 on Wednesday. The firm’s 50 day simple moving average is $72.40 and its two-hundred day simple moving average is $66.84. Sonova has a 1-year low of $54.18 and a 1-year high of $77.56. The company has a current ratio of 1.45, a quick ratio of 1.07 and a debt-to-equity ratio of 0.63.

About Sonova

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.